The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Sponsor
Ministry of Health, Malaysia (Other)
Overall Status
Unknown status
CT.gov ID
NCT01310062
Collaborator
GeneNews Sdn Bhd (Other)
1,600
8
24
200
8.3

Study Details

Study Description

Brief Summary

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1600 participants
    Time Perspective:
    Cross-Sectional
    Official Title:
    Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
    Study Start Date :
    Aug 1, 2010
    Anticipated Study Completion Date :
    Aug 1, 2012

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      21 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Patients of at least 21 years old on day of giving consent for study

      • Patients must be able and wiling to give an informed consent

      • Patient with chronic HBV infection

      • Patient with active hepatocellular carcinoma and chronic hepatitis B

      • Healthy subjects

      Exclusion Criteria:
      • Patients who have co-infection with HIV or chronic hepatitis C

      • Subjects with other types of cancer

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Sultanah Bahiyah Hospital Alor Star Kedah Malaysia
      2 Queen Elizabeth Hospital Kota Kinabalu Sabah Malaysia
      3 Hospital Umum Kuching Sarawak Kuching Sarawak Malaysia
      4 Selayang Hospital Selayang Selangor Malaysia
      5 Kuala Lumpur Hospital Kuala Lumpur Wilayah Persekutuan Malaysia
      6 Island Hospital Pulau Pinang Malaysia
      7 Lam Wah Ee Hospital Pulau Pinang Malaysia
      8 Penang Hospital Pulau Pinang Malaysia

      Sponsors and Collaborators

      • Ministry of Health, Malaysia
      • GeneNews Sdn Bhd

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT01310062
      Other Study ID Numbers:
      • 09-317-3991
      First Posted:
      Mar 7, 2011
      Last Update Posted:
      Mar 7, 2011
      Last Verified:
      Mar 1, 2011

      Study Results

      No Results Posted as of Mar 7, 2011